Pitié-Salpêtrière University Hospital is a teaching hospital in the 13th arrondissement of Paris. Part of the Assistance Publique – Hôpitaux de Paris and a teaching hospital of Sorbonne University, it is one of Europe's largest hospitals. It is also France's largest hospital.

During the past decade, Service des maladies infectieuses et tropicales Hopital Pitie salpetriere conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Service des maladies infectieuses et tropicales Hopital Pitie salpetriere" #1 sponsor was "French National Agency for Research on AIDS and Viral Hepatitis" with 3 trials, followed by "ANRS, Emerging Infectious Diseases" with 2 trials sponsored, "Bristol-Myers Squibb" with 2 trials sponsored, "Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida" with 2 trials sponsored and "Gilead Sciences" with 2 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Service des maladies infectieuses et tropicales Hopital Pitie salpetriere" #1 collaborator was "Bicetre Hospital" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "INSERM UMR S 1136" with 1 trials as a collaborator, "Institut National de la Santé Et de la Recherche Médicale, France" with 1 trials as a collaborator and "Pitié-Salpêtrière Hospital" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Service des maladies infectieuses et tropicales Hopital Pitie salpetriere" are "HIV Infections" (7 trials), "HIV-1 Infection" (2 trials), "HIV" (1 trials), "HIV Infected Patients With Cancer Treated by ICPi" (1 trials) and "HIV Lipodystrophy Syndrome" (1 trials). Many other conditions were trialed in "Service des maladies infectieuses et tropicales Hopital Pitie salpetriere" in a lesser frequency.

Most popular intervention types in "Service des maladies infectieuses et tropicales Hopital Pitie salpetriere" are "Drug" (8 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "non-nucleoside reverse transcriptase inhibitors" (2 trials), "nucleoside reverse transcriptase inhibitors" (2 trials), "ARV bitherapie" (1 trials), "Atazanavir" (1 trials) and "Blood sample" (1 trials). Other intervention names were less common.

The vast majority of trials in "Service des maladies infectieuses et tropicales Hopital Pitie salpetriere" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Service des maladies infectieuses et tropicales Hopital Pitie salpetriere". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Service des maladies infectieuses et tropicales Hopital Pitie salpetriere, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Service des maladies infectieuses et tropicales Hopital Pitie salpetriere, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".